Author: Charmaine Fraser

Dr Frances Brightman and Dr Eric Fernandez have been accepted to present their posters at the AACR Annual Meeting 2013, which will take place April 6-10 in Washington, DC. The posters entitled “drugCARD: a database of anticancer treatment regimens and drug combinations” (#5147) and “Modeling ionizing radiation exposure in vitro and in vivo using the Virtual Tumour” (#5233) will present the latest technology advances developed...

Read More

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has been recognised by the French Ministry of Higher Education and Research as an eligible research organisation for French companies seeking to claim French Research and Development tax credits (“Agrément crédit d’impôt recherche") on their research projects (2012 to 2014). Read more...

Read More

Chairman’s Statement   Summary of Results in the year ended 30 June 2012   Fundraising in April 2012 generated cash of £555,000 before issue expenses. The turnover of the Company more than doubled to £135,306 (2011: £53,345). The operating loss reduced to £577,922 (2011: £693,795). On 30 June 2012 the surplus of shareholders’ funds was £734,570 (2011: £755,511). With a now fully validated Virtual Tumour technology, Physiomics has concentrated...

Read More

Further to the announcement that a poster will be shown at the PKUK 2012 meeting, Dr Eric Fernandez will give a talk at the conference on the Friday 11th of November, entitled "A database of PK-PD parameters and information for the modelling of anti-cancer treatment regimens and drug combinations". Please click here for more information on the conference. ...

Read More

Dr Frances Brightman has been accepted for a poster presentation at PKUK 2012 meeting. Frances will show an update on the anti cancer drug combination database research program. Please click here for more information on the conference. ...

Read More